Objective-To study the trends in the incidence of invasive cervical cancer in East Anglia. Design-Statistical analysis ofage specific incidence rate for the period 1971-93 using East Anglian Cancer Registry data. Subjects-All cases of invasive cervical cancer registered with the East Anglian Cancer registry, diagnosed in the period 1971-93.
One of the key areas in the Health of the Nation strategy' is a reduction in the incidence of cervical cancer by about 20% to 12/100 000 by the year 2000. Cervical cancer is potentially one of the most preventable cancers. Unlike many other cancers, there is an easily detectable and normally prolonged premalignant phase and a suitable screening test, the cervical smear. The aim of cervical screening is therefore the prevention of the development of invasive cervical cancer by the detection and treatment of preinvasive lesions. Reduction in mortality from the disease should then result from the reduction in incidence of invasive cancer. As five year survival for cervical cancer in the United Kingdom is about 60%,2 change in incidence will be an earlier and more sensitive measure of the effectiveness of a screening programme than changes in mortality, and, in particular, a more sensitive measure of the effect of changes introduced to the programme.
The potential of mass cytological screening for invasive cancer of the cervix to reduce morbidity and mortality from the disease is now acknowledged. The Nordic countries have provided the clearest supportive data. The five Nordic countries, with uniformly high levels of medical care, adopted very different policies towards screening. The sharply contrasting trends both in incidence and in mortality' 4 from cervical cancer seen in the Nordic countries since the mid-1960s reflect closely the different levels of organised screening. Similar results in this country have been reported from north east Scotland, where a well organised programme has been in operation since the 1960s. 5 For individual women the reduction in risk of developing an invasive cervical cancer after taking part in a screening programme has been estimated in terms of the number of previous screening tests, and the time elapsed since the last negative test." Combining these reductions in risk with estimation of population coverage over time predicts closely the changes in incidence seen in Nordic countries.'
The effectiveness of screening depends upon the interval between screens, laboratory quality, the follow up of abnormal smears, and coverage of the population." Cervical screening was introduced in the United Kingdom in the mid to late 1960s with an increasing number of smears being taken over the years. The reduction in incidence and mortality, however, by the end of the 1980s was considerably less than expected, particularly given the resources that were allocated to it. Organisational inadequacies, leading to poor uptake and failures to follow up abnormal smears, were part of the problem. Evidence from a number of areas indicates that poor quality screening also contributed to the disappointing lack of effectiveness. Highly publicised incidents in recent years have shown that in a number of cytopathology laboratories the quality of screening has been inadequate, with many abnormal smears being accepted as normal. 9 In 1985 the Department of Health and Social Services made the district health authorities responsible for implementing computer managed call and recall schemes DA(85)8, and in 1988 issued a circular (HC(88) 1) with the guidelines. These guidelines included fail safe procedures for the follow up of women with abnormal smears and assignment of responsibility for the follow up specifically to the director of each cytopathology laboratory. In 1989 general practitioners' contracts were introduced, with financial incentives. for achieving targets for the proportion of women screened in the previous five years. These two measures produced a substantial increase in the proportion of women reported to have been screened within the past five years (table  1) . Some of this increase may be due to improved reporting, resulting from the new financial incentives and improved technology, but much of the apparent increase should be real. We present the trends in incidence of cervical cancer in the districts of East Anglia since 1971 and discuss these in relation to the screening programme, in particular the organisational changes that took place in the late 1980s. We also show that although monitoring the incidence rate of cancers at the district level is apparently hampered by the small numbers of cases, modern statistical techniques can be used to improve the precision with which trends are estimated.
Subjects and methods
Detailed information, including stage, morphological type, and district of residence at diagnosis, has been collected on all cases of invasive cervical cancer registered with the East Anglian Cancer Registry since 1971. This report is based on registrations to 31 December 1995. As over 98% of cervical cancer cases are recorded in the East Anglian region within 24 months from the end of the year of diagnosis, we have considered the 23 year period 1971-93 inclusive. East Anglia, until 1992, was made up of eight district health authorities-Cambridge, Huntingdon, Peterborough, Great Yarmouth and Waveney, West Norfolk and Wisbech, Norfolk, West Suffolk, and East Suffolk. Residence was coded to these districts for all cases diagnosed between 1971 and 1993. The registry paper records were checked and compared with the computer records. Where necessary, details of cases were amended or added. Extraregional registrations-that is, women who had been treated or diagnosed at a hospital in East Anglia but were not normally resident in the region, and carcinoma in situ cases, were excluded. Population denominator data by age and district health authority were available from the cancer registry. STATISTICAL METHODS Regional cancer incidence rates within four age groups for the period 1971-93 were calculated; as the effect of screening women aged 25-64 should be seen within a few years in the 65-69 age group, the grouping chosen was 20-34, 45 35-49, 50-69, and 70 years and above. The annual rate of change between 1971 and 1990 was estimated using Poisson regression," and repeated for the eight individual districts. Variability between districts needs to be taken into account when calculating interval estimates and assessing significance of changes in regional incidence; this is accomplished by multilevel modelling,II which in this context takes the form of random effects Poisson regression," in which district levels and trends are assumed to be distributed around the regional level and trend. Monte Carlo simulation methods (Gibbs sampling)" were used for interval estimates of the regional trends in each age category, for estimating district-specific trends, and to predict the number of cases expected in 1991-93 based on these trends (see Appendix). The resulting distribution of simulated numbers of cases in 1991-93 within each age group allows the expected number of cases to be compared with the observed number, and this is used to calculate a point and interval estimate of the percentage reduction of observed to expected. Figure 1 shows the annual incidence rates by age group for the 20 year period 1971-90. Figure 2 illustrates the variation in trends across the districts for the age group 35-49. Similar variation by district is seen for the other age groups. Based on the age and district specific rates for 1971-90 (see Methods section) the expected numbers of cases were calculated for 1991-93, by age group, for the entire region. Table 2 compares the observed number of cases with those expected. Based on the random effects modelling of the trends for 1971-90, simulation provides predictions of the expected numbers for 1991-93, whose distribution gives the 95% uncertainty interval for the percentage reduction seen in 1991-93. In the age group 20-69, for which an improved delivery of screening might be expected to have an effect, there was a highly significant 34% reduction in the rate of invasive cervical cancer. For women aged 70 or more the reduction in incidence was considerably lower (12%) and of no statistical significance.
Results
Information on stage at diagnosis is not consistently available throughout the time period considered. In recent years, however, stage information is available in more than 90% of cases under 70 years of age. The proportion classified as stage 2 or more advanced fell from 33% for the years 1988-90 to 25% for the years 1991-93.
Discussion
The original focus of this study, which started in 1993, was an assessment of the variation in the effectiveness of the programme between districts in East Anglia, as measured by trends in the incidence of invasive cervical cancer related to screening uptake. The initial results (fig 2) Gibson, Spiegelhalter, Camilleri-Ferrante, Day indicated that substantial variation existed between districts. Cervical cytology services in East Anglia are organised on a district basis, and variation between districts might identify district programmes that were relatively underperforming. A principal aim, motivated by the Inverclyde inquiry; was the identification of intermediate measures of performance of the programme in a district that would be predictive of effectiveness as shown by reduced incidence and mortality. Later results (table 2) showed, however, that major changes in incidence trends occurred in East Anglia after the changes in the organisation of the programme and in the financial arrangements for those responsible for taking the smears, introduced in the late 1980s.
Recent results from a single district in the South West region displayed a shift towards an earlier stage at diagnosis but little change in overall incidence. 14 Apparently contrary findings were reported from another district of the United Kingdom," in which only minor reductions in cervical cancer mortality occurred despite cytological abnormalities being detected in many thousands of women. The increase in the number of abnormalities being detected, particularly in younger women, is a cause for concern, an issue which is accentuated by screening women under age 25 when invasive cancer is extremely rare. The relative lack of benefit that was reported, however, reflects the lack of focus in their analysis. Five year moving averages of mortality that end in the period 1988-92 would be highly insensitive to the changes reported here.
A range of explanations must be considered for the results we have reported. The reduction in incidence seen in the most recent years might be ascribed to delays in registration. This explanation is untenable, however, as more than 98% of 1993 diagnoses should have been registered by the end of 1995, and virtually all 1991 and 1992 diagnoses. Changes in lifestyle, as reflected in a fall in reported sexually transmitted disease, might underlie some of the decrease. This explanation is also implausible, however, as the decrease in incidence occurred in all age groups and was most notable in those aged 50-69. There is no evidence of substantial change in risk behaviour in this age group, nor that changes in risk behaviour would lead to an immediate fall in incidence.
The most plausible explanation is that changes to the screening programme introduced in the late 1980s have made a marked improvement in programme effectiveness.
The specific improvement likely to have had most impact on cervical cancer incidence rates is the increase in population coverage. Part of the change seen in table 1 is probably artefactual-i-that is, the result of improved information systems and incentives to general practitioners to report more accurately their screening activity. Nevertheless, even if the true coverage in 1988-89 were nearer to 60% rather than the reported 40%, the increase to over 80% seen in 1991-92 would have been sufficient to bring about the observed reduction in incidence, given the powerful and immediate effect of screening." As earlier reports clearly showed that most women who had developed cervical cancer had not had an adequate smear taken in the previous five years, a decrease in the number of women in this category would have been the single most effective step to reduce cervical cancer incidence.
Probably, however, other changes introduced in the late 1980s had additional beneficial effects, notably the introduction of fail safe procedures to ensure adequate follow up of women with abnormal or inadequate smears, with specific responsibility assigned to the laboratories. Failures offollow up were the second major contributor to the lack of effectiveness of the screening programme seen in earlier years. The main conclusion to be drawn is that unorganised, untargeted screening activities are wasteful of resources. As Nordic experience 47 has shown, the potential of cervical screening is most effectively realised by centrally organised programmes. The changes introduced in the United Kingdom in the late 1980s seem to have provided the organised structure required.
